Recently published research from GlobalData, "RTI Biologics, Inc. Market Share Analysis", is now available at Fast Market Research

Boston, MA -- (SBWire) -- 02/06/2013 --GlobalData's new report, "RTI Biologics, Inc. Market Share Analysis" provides in-depth information on RTI Biologics, Inc.'s market position in the orthobiologics market. The report also provides data and information on the overall competitive landscape within the orthobiologics market. The report is supplemented with global corporate-level profile with information on the company's business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

View Full Report Details and Table of Contents

Scope

- Global company shares (in Revenues) information for the orthobiologics market.
- RTI Biologics, Inc.'s company shares (in Revenues) information for all the key countries the company has presence in - United States and Canada.
- RTI Biologics, Inc.'s company shares (in Revenues) information for the orthobiologics market.
- All the key data-points are for 2011 and cover all the key regions - North America.
- Global corporate-level profile with information on the company's business segments, major products and services, competitors, and locations and subsidiaries.
- Comprehensive coverage of the latest financial deals involving the company and its subsidiaries.

Reasons to Get this Report

- Develop sales and marketing strategies by identifying who-stands-where in the markets, RTI Biologics, Inc.'s operates in.
- Plan your competition strategies by identifying the company's shares in the markets and geographic regions it operates in.
- Design your own inorganic growth and business-collaboration strategies by understanding the financial deals your competitors are involved in.
- Advance your understanding of the competitive landscape and the competitors by leveraging on the data and information provided in the report.
- Support your overall business strategies by leveraging on the key data and information provided in the report, which includes but not limited to RTI Biologics, Inc.'s market positions.

Companies Mentioned in this Report: Medtronic, Inc., DePuy Synthes Companies, Genzyme Corporation, Synthes, Inc., Biomet, Inc., Smith & Nephew Plc, Seikagaku Corporation, Baxter International Inc., DJO Finance LLC, Orthofix International N.V., NuVasive, Inc., Stryker Corporation, AlloSource, Wright Medical Group, Inc., Globus Medical, Inc., Anika Therapeutics, Inc., Ferring International Center S.A., Alphatec Holdings, Inc., Adaptaide Inc., Exactech, Inc., Japan Medical Dynamic Marketing, Inc., Korea Bone Bank Inc., KYOCERA Medical Corporation, Australian Biotechnologies, curasan AG, Bonovo Orthopedics, Inc.

About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Medical Devices research reports at Fast Market Research

You may also be interested in these related reports:

- RTI Biologics, Inc. (RTIX) - Product Pipeline Analysis
- Wright Medical Group, Inc., Market Share Analysis
- Spine Surgery Devices Market Forecasts to 2017 - Global Trends & Competitive Analysis
- Zimmer Holdings, Inc. Market Share Analysis
- Biomet, Inc. Market Share Analysis
- RTI Biologics, Inc. (RTIX) - Medical Equipment - Deals and Alliances Profile
- Active Pharmaceutical Ingredients (API) Market in Europe to 2017 - Pricing and Reimbursement Initiatives Supporting Generic Drug Growth, with CMOs Expected to Account for Majority of the Manufacturing Activity
- Active Pharmaceutical Ingredients (API) Market in the Americas to 2017 - Shift Towards Generics and Biosimilars as South and Central America Emerges as a Key Growth Region
- Active Pharmaceutical Ingredients (API) Global Market to 2017 - Growth in Developing Markets to Come From Cost Efficient Manufacturing and Rising Domestic Demand
- Active Pharmaceutical Ingredients (APIs) Market in Asia Pacific to 2017 - Increasing Penetration in China and India Coupled with Low Cost Manufacturing to Fuel Regional Growth